Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
US6380258B2 · kind B2 · utility
9Cited by
8References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 1999 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | Jun 24, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/15
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A sulfonyl divalent aromatic or heteroaromatic ring hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a treatment process that comprises administering a contemplated sulfonyl divalent aromatic or heteroaromatic ring hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.